These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. FDA needs more sophisticated approach to drug safety. Christie B BMJ; 2005 May; 330(7501):1166. PubMed ID: 15905236 [No Abstract] [Full Text] [Related]
25. Biomarker qualification pilot process at the US Food and Drug Administration. Goodsaid F; Frueh F AAPS J; 2007 Mar; 9(1):E105-8. PubMed ID: 17408233 [TBL] [Abstract][Full Text] [Related]
26. Combination products regulation at the FDA. Lauritsen KJ; Nguyen T Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151 [TBL] [Abstract][Full Text] [Related]
27. Legal considerations--testing the "residue of toxicological concern". Landa MM Drug Metab Rev; 1995; 27(4):581-90. PubMed ID: 8925719 [No Abstract] [Full Text] [Related]
28. [Counterfeit and fake drugs: medications that kill]. Ambroise-Thomas P Med Trop (Mars); 2010 Jun; 70(3):213-4. PubMed ID: 20734583 [No Abstract] [Full Text] [Related]
29. "Fast tracking" drug approvals: is consumer safety being compromised? Jacobsen K QRC Advis; 2000 Jun; 16(8):5-9. PubMed ID: 10977137 [No Abstract] [Full Text] [Related]
30. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval. Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083 [TBL] [Abstract][Full Text] [Related]
31. Paving the way for safer, more effective drugs, food, and medical products. Casciano DA FDA Consum; 2005; 39(6):8-11. PubMed ID: 16669112 [No Abstract] [Full Text] [Related]
32. Beware of new drugs, study suggests. Levenson D Rep Med Guidel Outcomes Res; 2002 May; 13(10):1-2, 5. PubMed ID: 12492085 [No Abstract] [Full Text] [Related]
33. FDA drug information that never reaches clinicians. Messerli FH; Bangalore S N Engl J Med; 2010 Feb; 362(6):562; author reply 563. PubMed ID: 20175300 [No Abstract] [Full Text] [Related]
34. New drugs and product approvals from 2000. Taylor SE; Gage TW Tex Dent J; 2001 Nov; 118(11):1070-81. PubMed ID: 11806330 [No Abstract] [Full Text] [Related]
35. Should new drugs be avoided? Child Health Alert; 2002 Jun; 20():2. PubMed ID: 12096722 [No Abstract] [Full Text] [Related]
37. Post-market drug safety evidence sources: an analysis of FDA drug safety communications. Ishiguro C; Hall M; Neyarapally GA; Dal Pan G Pharmacoepidemiol Drug Saf; 2012 Oct; 21(10):1134-6. PubMed ID: 23033257 [No Abstract] [Full Text] [Related]
38. [Letters from Washington. Food and Drug Administration and medical technology: at an impasse?]. Gelijns AC Ned Tijdschr Geneeskd; 1993 Jan; 137(3):146-50. PubMed ID: 8423866 [No Abstract] [Full Text] [Related]
39. FDA implementation of standards developed by the International Conference on Harmonisation. Booth PM Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561 [No Abstract] [Full Text] [Related]